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Purpose: To assess the validity of individual and combined prognostic 
effects of severe bronchopulmonary dysplasia (BPD), brain injury, 
retinopathy of prematurity (ROP), and parenteral nutrition associated 
cholestasis (PNAC). 
Methods: We retrospectively analyzed the medical records of 80 
extremely low birthweight (ELBW) infants admitted to the neonatal 
intensive care unit (NICU) of the Severance Children’s Hospital, and 
who survived to a postmenstrual age of 36 weeks. We analyzed the 
relationship between 4 neonatal morbidities (severe BPD, severe 
brain injury, severe ROP, and severe PNAC) and poor outcome. Poor 
outcome indicated death after a postmenstrual age of 36 weeks 
or survival with neurosensory impairment (cerebral palsy, delayed 
development, hearing loss, or blindness) between 18 and 24 months 
of corrected age. 
Results: Each neonatal morbidity correlated with poor outcome on 
univariate analysis. Multiple logistic regression analysis revealed that 
the odds ratios (OR) were 4.9 (95% confidence interval [CI], 1.0-
22.6; P=0.044)  for severe BPD, 13.2 (3.0-57.3; P<.001) for severe 
brain injury, 5.3 (1.6-18.1; P=0.007) for severe ROP, and 3.4 (0.5-
22.7; P=0.215) for severe PNAC. Severe BPD, brain injury, and ROP 
were significantly correlated with poor outcome, but not severe 
PNAC. By increasing the morbidity count, the rate of poor outcome 
was significantly increased (OR 5.2; 95% CI, 2.2-11.9; P<.001). In 
infants free of the above-mentioned morbidities, the rate of poor 
outcome was 9%, while the corresponding rates in infants with 1, 2, 
and more than 3 neonatal morbidities were 46%, 69%, and 100%, 
respectively. 
Conclusion: In ELBW infants 3 common neonatal mornidifies, 
severe BPD, brain injury and ROP, strongly predicts the risk of poor 
outcome.
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Introduction 
With advances in perinatal and neonatal intensive care, the 
survival rate of extremely low birthweight (ELBW) infants has 
increased remarkably. The estimated survival rate of ELBW infants 
was higher than 70% in Japan, America and other countries in 
early 20001-3), and 62.4% in Korea and 89% in Severance Hospital 
in 20071). The long term quality of life in ELBW infants therefore 
needs much consideration; survivors remain at high risk of late 
death and neurodevelopmental impairments, such as cerebral palsy 
(CP), cognitive delay, deafness and blindness4-6).
However, predicting the long term outcome of ELBW infants 
is still difficult7, 8). Current risk scoring systems such as the Score 
for Neonatal Acute Physiology (SNAP) and Clinical Risk Index 
for Babies (CRIP)9-12) are limited during the first few days and 
weeks after birth because their predictability is compounded by 
the ongoing influence of neonatal morbidities and adverse events 
due to prolonged hospitalization8,13). Bronchopulmonary dysplasia 
(BPD) is one of the major neonatal morbidities which have an 
impact on poor outcome, such as cerebral palsy, blindness and late 
death14,15). Severe intraventricular hemorrhage (IVH), extensive 
periventricular leukomalasia (PVL), and posthemorrhagic 
hydrocephalus requiring shunt insertion are also related to poor 
cognitive outcomes15,16). Retinopathy of prematurity (ROP) is 
associated with later visual impairment17). Additionally, recent 
reports have mentioned the association between undernutrition 
during brain growth and neurodevelopmental outcome18,19). 
Since most ELBW infants are affected with several morbidities in 
the same period7, 8), it may not be possible to predict poor long term 
outcomes from individual neonatal morbidities. So Schmidt et al.7) 
made attempts to predict long term outcomes by the combination 
of 3 neonatal morbidities. They reported that 3 neonatal 
morbidities (severe BPD, severe brain injury and severe ROP) are 
individually or collectively correlated with poor outcomes such as 
late death or survival with CP, delayed development, hearing loss, 
and blindness at 18 months of corrected age. They showed that the 
higher the morbidity count, the higher the risk of poor outcome. 
Consequently they were able to establish a simple logistic model 
that predicts poor outcome using the morbidity count. Bassler et 
al.8) went on to report the mediated effects of neonatal infection on 
this logistic model. 
This model suggested by Schmidt et al.7) is unique in that 
it applies a combination of neonatal morbidities to long term 
prognosis prediction. Such analysis has yet to be reported in Korea. 
In our study, severe parenteral nutrition associated cholestasis 
(PNAC) that reflects undernutrition was added to the three major 
neonatal morbidities. We undertook this study to examine the 
individual and combined prognostic impact of severe BPD, severe 
brain injury, severe ROP, and severe PNAC on the long term 
outcome of ELBW infants hospitalized at the Severance Neonatal 
Intensive Care Unit (NICU).
Materials and methods
1. Subjects
Two hundred and seventy-two ELBW infants weighing less than 
1,000 g were hospitalized at the NCIU of Severance Children’s 
Hospital, Yonsei University College of Medicine between January 1, 
1997 and December 31, 2007. The medical records of 111 patients 
surviving longer than a postmenstrual age of 36 weeks were 
examined retrospectively. Of these, follow-up observation records 
were available for 80 patients. These 80 patients were enrolled in 
the study. 
2. Methods  
1) Examination of neonatal morbidities 
The neonatal morbidities of ELBW infants were examined 
by dividing them to 4 categories: (1) BPD more than moderate 
severity, (2) severe brain injury such as PVL or IVH higher than 
grade 3, (3) severe ROP, and (4) severe PNAC. 
BPD was defined as the need for supplemental oxygen at a 
postmenstrual age of 36 weeks. According to severity based 
classification20), severe BPD was defined as requiring either 28 days 
of supplemental oxygen therapy with more than 30% oxygen, 
or nasal continuous positive airway pressure (CPAP) or positive 
pressure ventilation at 36 weeks’ postmenstrual age or discharge, 
whichever came first, in infants whose gestational age was younger 
than 32 weeks, or at 56 days’ postnatal age or discharge, whichever 
came first, in infants whose gestational age was older than 32 
weeks. Severe brain injury was defined as confirmed PVL by 
brain magnetic resonance imaging (cases only suspected by brain 
ultrasonography were excluded). Cases with IVH higher than 
grade 3 confirmed by brain ultrasonography or brain magnetic 
resonance imaging were included. ROP was diagnosed and 
classified according to the International Classification of Acute 
Retinopathy of Prematurity (ICROP)21). ROP cases showing the 
plus sign or those which underwent surgical treatment such as 
cryotherapy or laser photocoagulation were defined as severe ROP. 
Severe PNAC was defined as cholestasis development secondary to 
total parenteral nutrition, with a direct bilirubin value higher than 
5.0 mg/dL and persistent for longer than one month, in association 
with increased liver enzyme values (>70 IU/L).
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2) Examination of poor prognosis between 18 months and 
24 months 
The poor outcome of ELBW infants was divided broadly 
into two categories and examined. The two categories were (1) 
whether the infant died after a postmenstrual age of 36 weeks 
and (2) whether the findings of impairment such as CP, delayed 
development, hearing loss, blindness, etc. were found between 
the corrected ages of 18 months and 24 months. CP and delayed 
development were determined based on the evaluation of specialists 
of the rehabilitation department at our hospital. CP was defined 
as non-progressive motor disorder resulting in physical disability, 
chiefly in the area of body movement. In addition to such CP, 
the cases with developmental delay of more than 2 standard 
deviations (95%) on neurologic examination and which underwent 
rehabilitation as well as physical therapy were included in the 
‘delayed development’ category. Hearing loss was defined as more 
than 55dB by brainstem evoked response audiometry (BERA) 
22). Blindness was defined as corrected vision of 20/200 or lower 
with almost absent peripheral vision based on the judgment of 
ophthalmologists of our hospital.
3) Statistical analysis
The association of the 4 neonatal severe morbidities with ELBW 
infants was analyzed by Chi-square test (or Fisher’s exact test) and 
multiple logistic regression analysis was performed. For statistical 
analysis, the SAS v9.1 (SAS Institute Inc, Cary, NC) was used. A P 
value of less than 0.05 was considered to be statistically significant. 
Results 
1. General characteristic of the subject patients and their 
mother 
The average gestational age of the subject infants was 27.6±2.1 
(24.5-33.5) weeks, and the mean birth weight was 816±126 g (520 
-990). 51 (64%) infants were male, 29 (36%) were female and 
14% were born by the IVF-ET procedure (Table 1). The mean age 
of mothers was 31±4 years with premature rupture of membrane 
in 13 patients (16 %); 27 mothers (33%) were administered 
steroids prior to birth, and 28 had chorioamnionitis confirmed 
pathologically or by bacteria culture (Table 2).
2. The relationship of neonatal morbidities and poor 
prognosis 
The association of the 4 neonatal morbidities (severe BPD, 
severe brain injury, severe ROP, and severe PNAC) with death 
occurred after the postmenstrual age of 36 weeks and CP, delayed 
development, blindness, and hearing loss developing between 18 
months and 24 months were analyzed, and the odds ratio (OR) 
obtained. In univariate analysis, the OR of severe BPD was 3.2 (95 
% Confidence interval [CI], 1.0-9.8, P=0.037), the OR of severe 
brain injury was 5.1 (95 % CI, 1.6-16.2, P=0.004), the OR of 
severe ROP was 3.0 (95 % CI, 1.2-7.6, P=0.017), and the OR of 
severe PNAC was 5.7 (95 % CI, 1.1-29.5, P=0.038), and these were 
significantly associated with poor long term outcomes.
The number of patients of each category of poor outcome 
and their percentage were distinguished and presented. Of the 
Table 1. Baseline Characteristics of Infants            
Characteristics                                   No. (%)                   Range          
Birth weight* (g) 816±126 520-990
Gestational age* (wk) 27.6±2.1 24.5-33.5
Sex       
   Male  51 (64)
   Female 29 (36)     
Delivery mode
   C-sec 67 (84)     
    NSVD 13 (16)
Multiple gestation 65 (81)
IVF-ET 11 (14)
IUGR 40 (50)
1 minute APGAR*    2.4±0.3 0-5
5 minute APGAR*    4.3±1.8 0-7
Hospital day*  105±39 47-309
Ventilator duration* (d)    42±42 2-308
Oxygen duration* (d)    64±46 4-308
HMD  72 (90)     
Air leak syndrome   4 ( 5) 
PDA 36 (45)
NEC   3 ( 4)                        
*Values are mean±SD
Abbreviations: SD, standard deviation; C-sec, cesarean delivery; NSVD, 
normal spontaneous vaginal delivery; IVF-ET, in vitro fertilization and embryo 
transfer; IUGR, intrauterine growth restriction; APGAR, Apgar score; HMD, 
hyaline membrane disease; PDA, patent ductus arteriosus; NEC, necrotizing 
enterocolitis
Table 2. Baseline Characteristics of Mothers             
Characteristics No. (%)          
Age* (y)
PROM
PROM* (hr) 
Antenatal steroid
Chorioamnionitis
PIH 
Placenta abruption
Fetal distress†
31±4      
13 (16)    
138±75      
27 (33)
28 (35)     
33 (41)
  5 (  6)           
29 (37)           
*Values are mean±SD
†Increased or decreased fetal heart rate during a contraction or late 
deceleration on non-stress test (NST) 
Abbreviations: SD, standard deviation; PROM, premature rupture of 
membranes; PIH, pregnancy induced hypertension
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17 ELBW infants who developed BPD, 5 infants died after a 
postmenstrual age of 36 weeks and thus the mortality rate was 29.4 
%. Of the 18 patients who developed brain injury, 1 patient died 
after a postmenstrual age of 36 weeks (5.6%). Of the 17 remaining 
patients, 7 patients had CP (41.2%). Of the 37 patients who 
developed ROP, 4 patients died (10.8%) and 3 showed blindness 
(8.1%) (Table 3).
3. The significance of the combination of morbidities for 
long term prognosis
To adjust the effect of neonatal morbidities on each other, 
multiple logistic regression analysis was performed on the 
relationship of the 4 neonatal morbidities and poor long term 
prognosis. Severe BPD, severe brain injury, and severe ROP were 
significantly associated with poor long term outcomes, and the 
odds ratio was more increased [BPD, OR 4.9 (95% CI, 1.0-22.6), 
P=0.044; brain injury, OR 13.2 (95% CI, 3.0-57.3), P<.001; severe 
ROP, OR 5.3 (95% CI, 1.6-18.1), P=0.007]. After the removal 
of the effect of neonatal morbidities affecting each other, the 
correlation of the 3 neonatal morbidities to poor outcomes became 
higher than in univariate analysis. However, in multiple logistic 
regression analysis, PNAC was not significantly associated with 
poor long term outcomes [OR 3.4 (95% CI, 0.5-22.7), P=0.215]. 
As the morbidity count increased, the rate of poor long term 
outcomes also increased and they were significantly associated [OR 
5.2 (95% CI, 2.2-11.9), P<0.001] (Table 4).
Examining the rate of poor outcomes according to the com-
bination of neonatal morbidities, it was found that in cases who 
were not affected by the 4 neonatal morbidities, 9% showed poor 
outcomes. On the other hand, poor outcome was seen in 46% of 
cases affected with any one of these 4 morbidities, 69 % of cases 
affected with 2 morbidities of any combination, and 100 % in 
cases affected with 3 morbidities of any combination (Table 5,  Fig. 
1). 
Additionally, the morbidity count predicted the poor outcomes 
equally well in each of the 2 strata for birth weight (<750 g) and 
gestational age (<28 weeks) (Fig. 2). 
Discussion 
The increased survival rate of ELBW infants highlights the 
necessity of the consideration of quality of life in ELBW infants1-6). 
We examined the prognostic impact of severe BPD, severe brain 
injury, severe ROP, and severe PNAC on poor outcomes such as 
late death or neurodevelopmental impairment in ELBW infants 
between 18 and 24 months of corrected age.
Until now, birth weight and gestational age have traditionally 
been used as strong indicators for the risk of neonatal death13). 
Scoring systems use physiologic abnormalities (hypotension-
Table 3. Univariate Relationships Between Individual Neonatal Morbidity and Outcome at 18-24 Months of Corrected Age
Neonatal morbidity
Poor outcome: 
death or neurosensory impairment*
Components of poor outcome :
Death and Individual impairments, No/Total (%)
No/Total (%) OR (95% CI) P value Death CP DD HL Blindness
BPD
Present
Absent
11/17 (64.7)
23/63 (36.5)
3.2 (1.0-9.8) 0.037
5/17 (29.4)
1/63 (1.6)
1/12 (8.3)
10/62 (16.1)
6/12 (50.0)
14/62 (22.6)
1/12 (8.3)
6/62 (9.7)
2/12 (16.7)
2/62 (3.2)
Brain injury
Present
Absent
13/18 (72.2)
21/62 (33.9)
5.1 (1.6-16.2) 0.004
1/18 (5.6)
 5/62 (8.1)
7/17 (41.2)
4/57 (7.0)
9/17 (52.9)
11/57 (19.3)
0/17 (0)
7/57 (12.3)
3/17 (17.7)
1/57 (1.8)
ROP
Present
Absent
21/37 (56.8)
13/43 (30.2)
3.0 (1.2-7.6) 0.017
 4/37 (10.8)
2/43 (4.7)
7/33 (21.2)
4/41 (9.8)
12/33 (36.4)
8/41 (19.5)
6/33 (18.2)
1/41 (2.4)
3/33 (8.1)
1/41 (2.4)
PNAC
Present
Absent
7/9 (77.8)
27/71 (38.0)
5.7 (1.1-29.5) 0.038
5/  9 (55.6)
1/71 (1.4)
1/  4 (25.0)
10/70 (14.3)
2/  4 (50.0)
18/70 (25.7)
0/  4 (0)
7/70 (10.0)
1/  4 (25.0)
3/70 (4.3)
*The rate of poor outcome in the entire cohort was 34/80 (43%)
Abbreviations: OR, odds ratio; Cl, confidence interval; CP, cerebral palsy; DD, delayed development; HL, hearing loss; BPD, bronchopulmonary dysplasia; ROP, 
retinopathy of prematurity; PNAC, parenteral nutrition associated cholestasis
Table 4. Logistic Regression Analysis of Long-term Outcome
Model type, Terms
Regression  
coefficient (SE) 
OR (95% CI) P value 
Individual morbidities
Intercept
BPD
Brain injury
Severe ROP
Severe PNAC 
Morbidity count*
Intercept
Morbidity count
-2.18 (0.58)
1.58 (0.79)
2.58 (0.75)
1.68 (0.62)
1.21 (0.98)
-1.98 (0.51)
1.64 (0.43)
4.9 (1.0-22.6)
13.2 (3.0-57.3)
5.3 (1.6-18.1)
3.4 (0.5-22.7)
5.2 (2.2-11.9)
0.044
<.001
0.007
0.215
<.001
*Comprises the number present of BPD, brain injury, severe ROP and severe 
PNAC.
Abbreviations: OR, odds ratio; Cl, confidence interval; BPD, bronch-
opulmonary dysplasia; ROP, retinopathy of prematurity; PNAC, parenteral 
nutrition associated cholestasis
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hypertension, acidosis, hypoxia, hypercapnia, anemia, neutropenia), 
as in the Score for Neonatal Acute Physiology (SNAP)9), or clinical 
parameters (gestational age, birth weight, anomalies, acidosis, 
FiO2), as in the Clinical Risk Index for Babies (CRIB)
10). CRIB 
includes six parameters collected in the first 12 hour after birth, 
and SNAP has 26 variables collected in the first 24 hours. While 
these risk scoring systems may provide prognostic information for 
mortality, objective risk scores provide similar predictability when 
compared with the clinical judgment of experienced neonatologists 
based on birth weight, illness severity, low Apgar score, and 
therapeutic requirements9-13). Furthermore, such scores may not be 
useful for predicting long term outcome in survivors because their 
predictability is confused by the ongoing influence of neonatal 
morbidities during prolonged hospitalization8, 13, 15). 
BPD has been associated with low psychomotor development 
index scores and neurologic abnormalities including CP, poor 
mental development, blindness and late death. Frequent episodes 
of hypoxia secondary to airway constriction, poor caloric intake 
due to prolonged ventilation, frequent respiratory diseases, 
increase of the use of corticosteroid after birth, accompanying 
diseases such as ischemic encephalopathy, PVL, and IVH in BPD 
survivors could be causative factors in developmental delay14, 15). 
Severe brain injury is associated with poorer intellectual outcome. 
Severe IVH (grade III or IV), progressive hydrocephalus requiring 
ventricular peritoneal shunting, intraparenchymal hemorrhage, 
and extensive PVL are each independently associated with a poor 
prognosis (CP and abnormal psychomotor, or cognitive outcome) 
while the majority of infants with grade I or II IVH have normal 
neurodevelopmental outcome15, 16). ROP is also associated with 
later visual impairment and functional disability17). 
However, the clinical usefulness of each of these morbidities in 
predicting outcome is limited8). Up to 30% of ELBW infants with 
Table 5. Observed and Predicted Poor Outcome at 18-24 Months of 
Corrected Age in the Case of Combined Neonatal Morbidities 
Neonatal morbidities
Observed data
No/Total (%)
None
Single morbidity
BPD
     Brain injury
     Severe ROP
     Overall
2 Morbidities
     BPD+severe ROP
     BPD+severe PNAC
     Brain injury +severe ROP
     Severe ROP +severe PNAC
     Overall
3 Morbidities
BPD+severe ROP+severe PNAC
Brain injury+severe ROP+severe PNAC
Overall
4 Morbidities
2/23 (9)
2/6  (33) 
7/11 (64)
9/22 (41)
18/39 (46)
 2/3  (67)
 2/3  (67)
 4/5  (80)
 1/2  (50)
 9/13 (69) 
 3/3 (100)
 1/1 (100)
 4/4 (100) 
 1/1 (100) 
Abbreviations: BPD, bronchopulmonary dysplasia; ROP, retinopathy of 
prematurity; PNAC, parenteral nutrition associated cholestasis
Fig. 1. Probability of poor outcome in the study infants with 0, 1, 2, 3 
and all 4 neonatal morbidities. Observed rates of poor outcome between 
18-24 months of corrected age. Solid line indicates predictions based on 
the fitted morbidity count model; dotted line (←), the overall probability 
of a poor outcome between 18-24 month of corrected age (43%).
Fig. 2. Probability of poor outcome by morbidity count, stratified by birth weight (A) and gestational age 
(B). Observed rates of poor outcome. Dotted lines (←) indicate the overall probability of a poor 18-24 month 
outcome (43%).
A B
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normal cranial ultrasound have CP or low cognitive performance 
at 18 months of corrected age16). In our study, similarly, 
approximately 35.3% of patients affected by BPD showed good 
prognosis and 36.5% of patients unaffected by BPD showed poor 
outcomes such as death or neurological developmental impairment. 
This is because most ELBW infants have not only one morbidity 
but several neonatal morbidities in the same period8).
Schmidt et al.7) therefore made attempts to predict long term 
outcomes by the combination of 3 neonatal morbidities (severe 
BPD, severe brain injury and severe ROP). They showed that 3 
neonatal morbidities are individually or collectively correlated with 
poor outcomes such as late death or survival with CP, delayed 
development, hearing loss, and blindness at 18 months of corrected 
age. More specifically, in infants who were free of severe BPD, brain 
injury and ROP, the rate of poor long term outcome was 18% and 
corresponding rates with any 1, any 2, and all neonatal morbidities 
were 42%, 62% and 88%, respectively. This shows that the higher 
the morbidity count, the higher the risk of poor outcome. A simple 
count of 3 neonatal morbidities strongly predicts the risk of later 
death or neurosensory impairment. Therefore they established 
a simple logistic model that predicts poor outcome by using 
morbidity count. After this, Bassler et al.8) reported the mediated 
effects of neonatal infection on this logistic model. Neonatal 
infection is also significantly associated with poor outcomes such 
as late death or survival with neurosensory impairment. However, 
infection was a weaker predictor of poor outcome than BPD, brain 
injury, and severe ROP. When any type of infection was added 
to the 3 morbidity-count model suggested by Schmidt et al., the 
rates of poor prognosis were further increased. More specifically, 
in the sepsis group, the rate of poor long term outcome in infants 
who were free of severe BPD, brain injury, and ROP was 18% and 
corresponding rates with any 1, any 2 and all neonatal morbidities 
were 50%, 68% and 100%, respectively8). 
Related studies have yet to be reported in Korea. Our study was 
conducted to see if the morbidity count model of Schmidt et al.7) 
could be applied to ELBW infants hospitalized at the Severance 
NICU. Additionally, we added severe PNAC to this model based 
on recent reports that undernutrition during brain growth is 
associated with neurodevelopmental deficits as we thought that 
severe PNAC may reflect undernutrition18, 19). Latal-Hajnal et al.18) 
have demonstrated that postnatal growth pattern, not being small 
for gestational age (SGA) at birth, is significantly associated with 
poor neurodevelopmental outcome at 24 months of corrected 
age. SGA infants who underwent insufficient catch-up growth 
and appropriate for gestational age (AGA) infants who underwent 
catch-down growth had significantly poorer mental and motor 
function than SGA infants who underwent substantial catch-up 
growth and AGA infants whose weight remained appropriate for 
age from birth to 24 months. The most recent reviews note that 
glutathione, ascorbic acid (vitamin C), riboflavin (vitamin B2) and 
tocopherol (vitamin E) deficiency during brain growth may induce 
brain injury secondary to oxidative stress and free radicals. These 
nutrients are major components of the body’s antioxidant system19). 
Our study confirms previous reports that severe BPD, severe 
brain injury, and severe ROP increase the risk of poor outcome 
in ELBW infants. Severe PNAC was significantly associated with 
poor outcome in univariate analysis, but was not significantly 
associated with poor outcome in multiple logistic regression 
analysis performed to eliminate the effect of the 3 other neonatal 
morbidities. In our study, in infants who were free of severe BPD, 
brain injury, ROP and PNAC, the rate of poor outcomes was 9%. 
Corresponding rates with any 1, any 2 and more than 3 neonatal 
morbidities were 46%, 69% and 100%, respectively. It also was 
found that higher morbidity counts were associated with greater 
risk of poor outcome. Compared with infants with no morbidity, 
infants with 1 morbidity have approximately double the risk of 
poor outcome, while 2 morbidities approximately triple the risk. 
This implies that 4 morbidities would have a similar effect on long 
term outcome. 
In infants who were not affected by any one of these 4 mor-
bidities, the rate of poor prognosis was 9% in our study (18% was 
shown in the study of Schmidt et al.). According to our definition, 
this portion may include infants affected by less than severe BPD, 
brain injury, ROP, or PNAC or neonatal infection and sepsis 
which are closely associated with poor outcome.
The significance of this study is the predictability of poor 
outcome for ELBW infants from measurement of simple morbidity 
count. Moreover, even the smallest and most immature infants 
have a favorable long term outcome if they survive the NICU stay 
without serious adverse events and morbidities such as BPD or 
ROP. 
In this study, we were not able to establish a logistic morbidity 
model due to the small cohort size. However, in terms of baseline 
characteristics, the incidences were comparable to other studies23, 24).
In the future, the morbidity count model needs to be proven to 
be practical by a prospective randomized large scale cohort study. 
It may then become a useful tool for medical teams planning long 
term treatment and parent counseling for ELBW infants.
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